Viewing Study NCT06205706


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-29 @ 2:31 PM
Study NCT ID: NCT06205706
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-19
First Post: 2023-12-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
Sponsor: BioInvent International AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module